返回 Agenda
Session 7: Joint Clinical Assessment (REA) Workshop
Session Chair(s)
Claudine Sapède, PHARMD
Director, Global HTA Policy
NOVARTIS INTERNATIONAL, Switzerland
This session will provide the opportunity for the audience to actively participate through small group discussions and share experience on a selection of themes related to JCA. Panellists from session 6 will join to facilitate support the group. • Uptake of REA Reports • Interface between JCA and National HTA Agencies Assessments • Methodological Quality Standards and Implications for Evidence Generation Development • Industry Preparedness for JCA Dossier Submission